Navigation Links
Kainos Capital Acquires Slim-Fast From Unilever
Date:7/10/2014

DALLAS, July 10, 2014 /PRNewswire/ -- Kainos Capital, a firm specializing in acquiring and managing food and consumer brands, today announced that it has acquired the Slim-Fast brand from Unilever. Unilever will retain a minority stake in the business. Terms of the transaction were not disclosed.

Slim-Fast is a branded weight loss and meal replacement business that markets ready-to-drink shakes, powders, bars and snacks to retail customers throughout North America and in the United Kingdom and Ireland.  The transaction includes the Slim-Fast trademark and the global Slim-Fast business portfolio.

Slim-Fast will be part of the Kainos Capital portfolio of health and wellness companies, which currently includes Milk Specialties Global, the largest value-added whey protein manufacturer in North America; InterHealth Nutraceuticals, an international provider of specialty nutraceutical ingredients; and Healthy Delights, an international branded marketer of supplement products including the popular line of nutritional confection chews and Nu-Life, a 50 year-old multivitamins brand. In 2013, Healthy Delights was named Vendor of the Year by GNC, a leading global specialty retailer of health and wellness products.

It was also announced today that Chris Tisi, the CEO and founder of Healthy Delights, will become the CEO of Slim-Fast as well.

Andrew Rosen, Managing Partner of Kainos Capital, said: "We are tremendously excited to acquire the Slim-Fast business in partnership with Unilever. Slim-Fast is the most recognizable brand name in weight management and over the last twenty years has helped millions of people lead healthier lives. Chris Tisi and his team have decades of experience in the diet and weight management category and are ready to give Slim-Fast the resources and entrepreneurial focus that will drive the brand to new heights."

Mr. Tisi said: "There is great opportunity to grow the Slim-Fast brand which already benefits from the highest aided and unaided brand awareness in the weight management category. I look forward to working with our retail partners and driving consumer engagement with dynamic marketing support and new product innovation."

About Kainos Capital
Kainos Capital is a middle market private equity firm with an exclusive focus on the food and consumer sector. The Kainos team has extensive investment and operating experience in the industry, having invested more than $2 billion of equity in more than 40 transactions with a total transaction value in excess of $7 billion. The firm's strategy is to build a diversified portfolio of growing and strategically relevant food and consumer businesses that trade buyers would like to acquire. For more information, visit Kainos Capital's website at www.kainoscapital.com.

Contact:

Mark Semer or Daniel Yunger
Kekst and Company
(212) 521-4800


'/>"/>
SOURCE Kainos Capital
Copyright©2014 PR Newswire.
All rights reserved

Related biology technology :

1. University at Albany: Governor Cuomo Announces Israeli Biotech Company Creating New Economic Opportunity In Capital Region
2. Arsenal Capital Partners übernimmt führendes Unternehmen für modellbasierte Arzneimittelentwicklung Certara
3. Arsenal Capital Partners verwerft Certara, leider in geneesmiddelontwikkeling op basis van modellen
4. Arsenal Capital Partners Acquires Leading Model-Based Drug Development Company Certara
5. Soligenix Announces Initial $600,000 Investment and up to $10.6 Million Common Stock Purchase Agreement with Lincoln Park Capital Fund, LLC
6. UCLA Venture Capital Fund Selects KYTHERA Biopharmaceuticals CEO Keith Leonard for First Annual Entrepreneurial Achievement Award
7. TVM Capital Group Announces Two-pronged Global Investment Strategy with Renewed MENA Focus
8. Foundation Venture Capital Group Portfolio Company Identifies FRY Gene As Breast Cancer Susceptibility Suppressor
9. S&P Capital IQ to Share Its Views on the Biotech Bull Market During the Next "ETF Analyst Hour"
10. Relmada Therapeutics Inc. Completes $8.0 Million Capital Raise In Series A Financing
11. Regado Biosciences, Inc. to Present at Aegis Capital Vegas Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... ... 25, 2017 , ... Throughout this webinar, participants will learn ... development and economic goals were achieved in both industry and academic settings. Attendees ... along with techniques for scaling production of mesenchymal stem cells (MSCs) and new ...
(Date:5/24/2017)... WEST BOUNTIFUL, Utah (PRWEB) , ... May 24, ... ... announces the selection and implementation of CLEARAS Water Recovery’s Advanced Biological Nutrient ... is a key component of a $24 million plant upgrade to sustainably meet ...
(Date:5/24/2017)... -- As Ebola resurfaces in the Democratic Republic ... cases now reported, a new analysis of the Ebola gene ... between the 2014 and 2017 outbreaks of the disease.  ... which preceded the 2014 outbreak. An analysis of the latest ... in 2014-15, which again precedes the current outbreak in the ...
(Date:5/23/2017)... ... May 23, 2017 , ... ... its 20th anniversary, marking the occasion with a strong presence at Bio-IT World ... Reception and further extends an invitation to all attendees to view posters ...
Breaking Biology Technology:
(Date:4/18/2017)... Inc., a global expert in SoC-based imaging and computing solutions, has ... features the company,s hybrid codec technology. A demonstration utilizing TeraFaces ® ... be showcased during the upcoming Medtec Japan at Tokyo Big Sight ... Las Vegas Convention Center April 24-27. ... Click here for an image of the ...
(Date:4/13/2017)... , April 13, 2017 UBM,s Advanced Design ... will feature emerging and evolving technology through its ... Summits will run alongside the expo portion of the ... panels and demonstrations focused on trending topics within 3D ... design and manufacturing event will take place June 13-15, 2017 ...
(Date:4/11/2017)... April 11, 2017 Crossmatch®, a globally-recognized ... solutions, today announced that it has been awarded ... Projects Activity (IARPA) to develop next-generation Presentation Attack ... "Innovation has been a driving force within ... will allow us to innovate and develop new ...
Breaking Biology News(10 mins):